{"DataElement":{"publicId":"6576570","version":"1","preferredName":"Gastric Cancer AJCC Edition 8 Clinical Tumor T Category","preferredDefinition":"Extent of the primary gastric carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"GAST_AJC8_CLN_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3443884","version":"1","preferredName":"Gastric Cancer Clinical T Stage","preferredDefinition":"Relating to the stomach._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3443882v1.0:2207100v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3443882","version":"1","preferredName":"Gastric Neoplasm","preferredDefinition":"Relating to the stomach.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C13307:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric","conceptCode":"C13307","definition":"Relating to the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E583-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BE9BBA38-E591-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"TAYLORT","dateModified":"2018-12-04","changeDescription":"12/3/18 tmt transferred context from NCIP. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6576420","version":"1","preferredName":"Gastric Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of gastric cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to all carcinomas that arise in the stomach. Gastrointestinal stromal tumors, sarcomas, lymphomas and well-differentiated neuroendocrine tumors (G1 and G2) are not staged using this staging system. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6576420v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Gastric Cancer pT4b TNM Finding v8","ValueMeaning":{"publicId":"6576422","version":"1","preferredName":"Gastric Cancer pT4b TNM Finding v8","longName":"6576422","preferredDefinition":"Gastric cancer with tumor invading adjacent structures/organs. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT4b TNM Finding v8","conceptCode":"C133616","definition":"Gastric cancer with tumor invading adjacent structures/organs. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-661E-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-6637-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Gastric Cancer pT4a TNM Finding v8","ValueMeaning":{"publicId":"6576424","version":"1","preferredName":"Gastric Cancer pT4a TNM Finding v8","longName":"6576424","preferredDefinition":"Gastric cancer with tumor invading the serosa (visceral peritoneum). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT4a TNM Finding v8","conceptCode":"C133615","definition":"Gastric cancer with tumor invading the serosa (visceral peritoneum). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-6644-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-665D-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T4","valueDescription":"Gastric Cancer pT4 TNM Finding v8","ValueMeaning":{"publicId":"6576426","version":"1","preferredName":"Gastric Cancer pT4 TNM Finding v8","longName":"6576426","preferredDefinition":"Gastric cancer with tumor invading the serosa (visceral peritoneum) or adjacent structures. The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum. Intramural extension to the duodenum or esophagus is not considered invasion of an adjacent structure, but is classified using the depth of the greatest invasion in any of these sites. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT4 TNM Finding v8","conceptCode":"C133614","definition":"Gastric cancer with tumor invading the serosa (visceral peritoneum) or adjacent structures. The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum. Intramural extension to the duodenum or esophagus is not considered invasion of an adjacent structure, but is classified using the depth of the greatest invasion in any of these sites. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-666A-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-6683-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T3","valueDescription":"Gastric Cancer pT3 TNM Finding v8","ValueMeaning":{"publicId":"6576428","version":"1","preferredName":"Gastric Cancer pT3 TNM Finding v8","longName":"6576428","preferredDefinition":"Gastric cancer with tumor penetrating the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum. Intramural extension to the duodenum or esophagus is not considered invasion of an adjacent structure, but is classified using the depth of the greatest invasion in any of these sites. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT3 TNM Finding v8","conceptCode":"C133613","definition":"Gastric cancer with tumor penetrating the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum. Intramural extension to the duodenum or esophagus is not considered invasion of an adjacent structure, but is classified using the depth of the greatest invasion in any of these sites. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-6690-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-66A9-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T2","valueDescription":"Gastric Cancer pT2 TNM Finding v8","ValueMeaning":{"publicId":"6576430","version":"1","preferredName":"Gastric Cancer pT2 TNM Finding v8","longName":"6576430","preferredDefinition":"Gastric cancer with tumor invading the muscularis propria. A tumor may penetrate the muscularis propria with extension into the gastrocolic or gastrohepatic ligaments, or into the greater or lesser omentum, without perforation of the visceral peritoneum covering these structures. In this case, the tumor is classified as T3. If there is perforation of the visceral peritoneum covering the gastric ligaments or the omentum, the tumor should be classified as T4. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT2 TNM Finding v8","conceptCode":"C133612","definition":"Gastric cancer with tumor invading the muscularis propria. A tumor may penetrate the muscularis propria with extension into the gastrocolic or gastrohepatic ligaments, or into the greater or lesser omentum, without perforation of the visceral peritoneum covering these structures. In this case, the tumor is classified as T3. If there is perforation of the visceral peritoneum covering the gastric ligaments or the omentum, the tumor should be classified as T4. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-66B6-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-66CF-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Gastric Cancer pT1b TNM Finding v8","ValueMeaning":{"publicId":"6576432","version":"1","preferredName":"Gastric Cancer pT1b TNM Finding v8","longName":"6576432","preferredDefinition":"Gastric cancer with tumor invading the submucosa. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT1b TNM Finding v8","conceptCode":"C133611","definition":"Gastric cancer with tumor invading the submucosa. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-66DC-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-66F5-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Gastric Cancer pT1a TNM Finding v8","ValueMeaning":{"publicId":"6576434","version":"1","preferredName":"Gastric Cancer pT1a TNM Finding v8","longName":"6576434","preferredDefinition":"Gastric cancer with tumor invading the lamina propria or muscularis mucosae. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT1a TNM Finding v8","conceptCode":"C133610","definition":"Gastric cancer with tumor invading the lamina propria or muscularis mucosae. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-6702-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-671B-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T1","valueDescription":"Gastric Cancer pT1 TNM Finding v8","ValueMeaning":{"publicId":"6576436","version":"1","preferredName":"Gastric Cancer pT1 TNM Finding v8","longName":"6576436","preferredDefinition":"Gastric cancer with tumor invading the lamina propria, muscularis mucosae, or submucosa. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT1 TNM Finding v8","conceptCode":"C133609","definition":"Gastric cancer with tumor invading the lamina propria, muscularis mucosae, or submucosa. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-6728-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-6741-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Gastric Cancer pTis TNM Finding v8","ValueMeaning":{"publicId":"6576438","version":"1","preferredName":"Gastric Cancer pTis TNM Finding v8","longName":"6576438","preferredDefinition":"Gastric cancer with a finding of carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pTis TNM Finding v8","conceptCode":"C133608","definition":"Gastric cancer with a finding of carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-674E-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-6767-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"TX","valueDescription":"Gastric Cancer pTX TNM Finding v8","ValueMeaning":{"publicId":"6576440","version":"1","preferredName":"Gastric Cancer pTX TNM Finding v8","longName":"6576440","preferredDefinition":"Gastric cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pTX TNM Finding v8","conceptCode":"C133606","definition":"Gastric cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-6774-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-678D-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"T0","valueDescription":"Gastric Cancer pT0 TNM Finding v8","ValueMeaning":{"publicId":"6576442","version":"1","preferredName":"Gastric Cancer pT0 TNM Finding v8","longName":"6576442","preferredDefinition":"Gastric cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT0 TNM Finding v8","conceptCode":"C133607","definition":"Gastric cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-679A-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C243788-67B3-26CC-E053-F662850AD9A1","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6576419","version":"1","preferredName":"Gastric Cancer TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of gastric cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to all carcinomas that arise in the stomach. Gastrointestinal stromal tumors, sarcomas, lymphomas and well-differentiated neuroendocrine tumors (G1 and G2) are not staged using this staging system. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C133595:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer TNM Finding v8","conceptCode":"C133595","definition":"A finding about one or more characteristics of gastric cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to all carcinomas that arise in the stomach. Gastrointestinal stromal tumors, sarcomas, lymphomas and well-differentiated neuroendocrine tumors (G1 and G2) are not staged using this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C243788-65F1-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C243788-6602-26CC-E053-F662850AD9A1","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"TAYLORT","dateModified":"2019-09-04","changeDescription":"8/30/19 TMT released per MC.; 12/3/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000182","version":"1","longName":"Stomach","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical T category","type":"Preferred Question Text","description":"Clinical T category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C3386AC-C1C9-31A9-E053-F662850A1CC3","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-04","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8/30/19 TMT released per MC.; 12/4/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}